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Chronic dyspnea is a potent, independent predictor of mortality and is prevalent in older 
adults, yet assessment is inadequate and validated instruments are lacking. Under-
reporting and poor perception are common, and older adults develop self-restriction 
strategies in order to improve breathing and quality of life. Chronic dyspnea-related 
diagnoses result in 32% of inpatient admissions for community-dwelling elders in the 
capstone study setting, but nurses do not use a validated dyspnea assessment instrument. 
Professional organizations universally recommend multidimensional assessment of 
dyspnea to improve early recognition of exacerbation. Emerging evidence indicates that a 
brief patient-reported questionnaire format may be the most reliable way to measure 
chronic dyspnea in the clinical setting. The DNP capstone explored the impact of using 
the Dyspnoea-12 Questionnaire (D-12) on nurse self-efficacy related to dyspnea 
assessment. Nurses were surveyed for six domains of self-efficacy before and after two 
months of patient assessment with the D-12. In spite of the small sample size (n = 10), 
improvement in nurse self-efficacy was demonstrated as a result of the intervention (χ2 = 
7.054 [p = .008]; φ = 0.108, [p = .008]). Nurses recommended the D-12 in patients with 
chronic dyspnea and at initial assessment, but not for universal use. Future research of the 
mD-12 in larger patient cohorts in varied settings, and further study of assessment 
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Assessment of Chronic Dyspnea in Older Adults: Impact of the Dyspnoea-12 
Questionnaire on Nurse Self-Efficacy 
Background and Significance 
 
Dyspnea is a symptom that nurses commonly encounter, affecting up to half of 
patients in acute care, and one-quarter in ambulatory care settings (Charles, Ng, & Britt, 
2005; Parshall et al., 2012). Chronic dyspnea is experienced by 25-46% of community-
dwelling adults aged 70 or older (Ahmed, Steward, & O’Mahony, 2012; Ho et al., 2001; 
van Mourik et al., 2014; Mullerova, Lu, Li, & Tabberer, 2014), and is a common 
complaint for older adults presenting to emergency departments and inpatient settings 
(Ahmed et al., 2012). Independent of age, gender, lung function, smoking, body mass 
index, and comorbidities, chronic dyspnea is a potent predictor of mortality that is 
associated with a 1.3 to 2.9 times greater risk of all-cause mortality at a 95% confidence 
interval (Berraho et al., 2013; Pesola & Ahsan, 2014).  
 Dyspnea is the sensation of difficult or uncomfortable breathing (Mukerji, 1990). 
Definitions of chronic dyspnea vary widely in clinical and research literature (Bausewein, 
Farquar, Booth, Gysels, & Higginson, 2006). Mahler and colleagues (2010) defined 
chronic dyspnea as difficult breathing that persists at rest, with minimal activity, or is 
distressful despite optimal therapy of advanced lung or heart disease (p. 674), versus 
Spector, Connolly, & Carlson (2007) who characterize chronic dyspnea as long-term, 
persistent, and varying in intensity. The most commonly used definition of dyspnea is 
that of the American Thoracic Society (ATS): 
“A subjective experience of breathing discomfort that consists of qualitatively 
distinct sensations that vary in intensity…The experience of dyspnea derives from 
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interactions among multiple physiological, psychological, social, and 
environmental factors, and may induce secondary physiological and behavioral 
responses…but we emphasize strongly that dyspnea per se can only be perceived 
by the person experiencing it. Perception entails conscious recognition and 
interpretation of sensory stimuli and their meaning. Therefore, as is the case with 
pain, adequate assessment of dyspnea depends on self-report” (Parshall et al., 
2012, p. 437). 
Dyspnea in older adults is complex, multifactorial, progressive, and characterized 
by repeated exacerbations. It is associated with chronic cardiorespiratory conditions such 
as heart failure (HF) and chronic obstructive pulmonary disease (Mahler et al., 2010; 
Parshall et al., 2012). Dyspnea is the most important disability-inducing factor in chronic 
obstructive pulmonary disease (COPD), greater than stage of illness or comorbidity 
(Braido et al., 2011). In a study comparing stable individuals with COPD and HF, 
researchers found that 100% reported dyspnea, yet no significant difference in the 
frequency of dyspnea, as measured by the number of times per month “severe to very 
severe dyspnea”. However, day-to-day intensity of dyspnea was significantly higher in 
subjects with COPD (de Souza Caroci & Lareau, 2004, p. 109). A review of nearly 
500,000 Medicare patients demonstrated that dyspnea and pain commonly occur, 
develop, and resolve together (Clark et al., 2014). “Breathlessness generates suffering 
across the community for patients and their caregivers often for long periods” (Currow, 
Higginson, & Johnson, 2013, p. 932).  
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Ineffective Recognition and Treatment 
Although thorough and accurate assessment is the universal cornerstone of 
clinical care and treatment, numerous authors emphasize that deficient assessment of 
chronic dyspnea is fundamentally associated with ineffective recognition, treatment, 
management, and outcomes related to cardiorespiratory conditions in older adults. 
Prompt recognition of the signs and symptoms of exacerbation in tandem with 
appropriate medication management can help prevent hospitalization in HF (Schipper, 
Coviello, & Chyun, 2012). Dyspnea is a predictor of hospitalization in COPD (Ong, 
Earnest, & Lu, 2005).  
The American College of Chest Physicians (ACCP) in their 2010 Consensus 
Statement on the Management of Dyspnea stated, “…patients with advanced lung or 
heart disease are not currently being treated consistently and effectively for relief of 
dyspnea” (Mahler et al., 2010, p. 674). Improved assessment of chronic dyspnea is 
critically needed to enhance earlier recognition, guide management and treatment, as well 
as impact avoidable hospitalization and decrease unnecessary healthcare expenditures.  
Older Adult Population and Dyspnea 
 For the purposes of this capstone, older adult is defined as an individual 65 years 
of age or older. There are 44.3 million Americans in this age group, 14.1% of the total 
population, more than at any other time in United States (U. S.) history (United States 
Census Bureau [USCB], 2013). The USCB projects that the population aged 65 and older 
will continue to grow dramatically until 2030, stabilizing at approximately 20% of the 
total population. However, as “Baby Boomers” (people born between 1946 and 1964) age 
to 85 and older, their numbers are expected to nearly quadruple from 5.5 million in 2010 
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to 19 million by 2050 (Federal Interagency Forum on Aging-Related Statistics [FIFA], 
2012, p. 22).  
U. S. Older Population Change 
Year Aged ≥ 65 years 
% Total U. S. 
population Aged ≥ 85 years 
1900   3 M     100 K 
2000  35 M   
2010  40 M     13%     5.5 M 
2030  72 M     20%  
2050        19 M 
 
Figure 1 U. S. Older Population Change (FIFA, 2012) 
 
 Due to the growth in the aging population, the prevalence of older adults with 
dyspnea will also rise. “Dyspnea, or breathlessness, is the most common symptom 
reported by patients with COPD and CHF seeking medical help” (de Souza Caroci, & 
Lareau, 2004, p. 102). Heart failure affects more than 5 million Americans; 12.7 million 
have diagnosed COPD (American Lung Association, 2014). Increasing age is associated 
with increasing prevalence in both diseases. COPD prevalence doubles each decade past 
middle age (Centers for Disease Control and Prevention, 2015), while HF increases 10-
fold between from age 60 to 80 (Go et al., 2014). COPD prevalence is 19.2% in 
Americans aged 70 or older (Buist et al., 2007), and projections indicate that COPD will 
become the third leading cause of death by 2030 (World Health Organization, 2008). 
Americans aged 80 or older have a 12.8-14.7% prevalence of HF (Azad & Lemay, 2014) 
with total population numbers expected to grow in association with an overall aging 
population.  
Gaps in Care 
   The clinical setting where this Doctor of Nursing (DNP) capstone was conducted 
is an outpatient department providing primary care in the place of residence to a cohort of 
140-150 majority older adults with chronic disease. Cardiorespiratory-related conditions 
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(CHF, COPD [including bronchitis], pneumonia, pulmonary fibrosis, respiratory failure 
and shortness of breath [SOB]) account for 32% of acute care admissions for the patient 
population—the most prevalent disease category. Hereafter, the capstone setting will be 
referred to as Site.  
Local nursing policies mandate the use of Lippincott’s Manual of Nursing 
Procedures (Nettina, 2014) for dyspnea assessment, which requires physical assessment 
and use of a single-item dyspnea assessment scale. Site nurses auscultate heart and lungs, 
take vital signs, oximetry and consistently ask, “Are you short of breath?” Current 
adherence only partially meets the standard of care; if the patient denies being short of 
breath, no scale is utilized. However, Site practices are consistent with general practice in 
that nursing dyspnea assessment usually does not include a validated tool (Baker et al., 
2013; Doran et al., 2014).  
Home Care Practice 
 Effective nursing assessment of elderly adults with chronic dyspnea in the 
community setting and related decision-making is a challenging dilemma, calling for 
study and creative clinical practice improvements. A group of nurse researchers who 
retrospectively investigated the application of clinical evidence to outcomes in home care 
stated, “There are gaps in knowledge about the extent to which home care nurses’ 
practice is based on best evidence and whether evidence-based practice impacts patient 
outcomes” (Doran et al., 2014, p. 274). Doran and colleagues (2014) noted that the home 
is an unpredictable environment, healthcare visits are short and episodic, nurses have 
more autonomy, and care is a shared approach with informal caregivers (p. 274). Of a 
total of 978 reviewed charts, 909 patients were assessed for dyspnea on admission (93%), 
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25.4% of which had dyspnea. Ninety-four percent had dyspnea present on both admission 
and discharge: only 10% showed improvement during the course of care, and dyspnea 
was unchanged or worse in 90%. Of the 20 evidence-based dyspnea interventions 
studied, only 5 were documented in 90% of the appropriate cases. Significant dyspnea 
score changes were associated with older age and a greater number of dyspnea 
interventions. Dyspnea was assessed via a single nurse-defined measure (0 = absence of 
symptoms to 3  = present at rest) of intensity (pp. 277-278). This study demonstrated that 
while home care nurses assessed dyspnea 93% of the time at admission, they did not 
elicit patient-reported indicators or physical factors such as oximetry with ambulation, 
nor did they employ more than 5 of 20 evidence-based interventions in their care (p. 
278). This large, very current study confirms the need for improvements in dyspnea 
assessment quality and consistency in the home care setting.  
Recliner Sleep Behavior  
 Dyspnea is recognizable in the home care environment where many elderly 
people sleep in a recliner chair rather than a bed, often for many years. An exhaustive 
literature review conducted between October and December 2014 failed to identify any 
publications that addressed the prevalence or problem of recliner sleep behavior. This 
author informally interviewed four experienced home care nurses and the Chiefs of 
Pulmonary and Physical Medicine and Rehabilitation in the local organization. All agreed 
that recliner sleep is a common phenomenon, but could likewise not identify any germane 
clinical or epidemiological evidence. Notably, while they agreed that people often sleep 
in recliners due to orthopnea or other respiratory-related issue, these experienced 
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clinicians were intrigued to have previously not considered recliner sleep behavior as a 
potential indicator of dyspnea that could/should be included in regular assessment.  
Theoretically, the foot-elevated semi-fowler’s position afforded by a recliner chair 
is a self-care measure to relieve orthopnea, defined as an increase in dyspnea while 
supine (Eltayara, Ghezzo, & Milic-Emili, 2001), or onset/worsening of dyspnea when 
shifting from the sitting to the supine position (Duguet et al., 2000). Orthopnea is a 
known risk indicator of poorly managed or progressive HF and COPD (Beck da Silva et 
al., 2004; Boni et al., 2005; Duguet et al., 2000; Eltayara et al., 2001; Mukerji, 1990; 
Torchio et al., 2006).  
Self-Restriction Strategies 
 Patients with chronic dyspnea, especially the elderly, develop a significant 
decrease in exercise tolerance that is directly proportionate to degree of airflow 
limitation. In an attempt to prevent worsening dyspnea, patients self-restrict physical 
activity, leading to a cycle of increasing exercise intolerance, progressive dyspnea, 
exacerbations, hospitalizations, and mortality. As activity of self-restriction and lifestyle 
adaptation becomes chronic, patients may underestimate the severity of their own 
condition (van der Molen, Miravitlles, & Kocks, 2013, p. 463). Perhaps recliner-sleeping 
behavior could be one such strategy that chronically dyspneic older adults use to control 
or adapt to orthopnea. Considering the clear ACCP consensus statement (Mahler et al., 
2010) and perplexing observation of chronic recliner sleep behavior, healthcare 
professionals may be missing an opportunity to recognize worsening respiratory status by 
not consciously including queries about sleeping posture in nursing dyspnea assessments. 
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Altered Symptom Reporting in the Elderly 
 Given that exacerbations of chronic cardiorespiratory conditions can be mitigated 
or managed prior to escalation and need for hospitalization, early recognition of signs and 
symptoms is critically important. However, in the elderly, self-perception and report of 
symptoms is a challenge. While older adults experience more dyspnea, their accuracy at 
detection and interpretation of early symptoms is worse than younger counterparts 
(Jurgens, Hoke, Byrnes, & Riegel, 2009). For example, a study of 103 patients found that 
those who scored five or more on a dyspnea visual intensity scale also answered “no” to 
the question “Are you short of breath?” (MacDonald, Yates, Lance, Giganti, & 
Chepurko, 2005, p. 260), indicating significant incongruity between younger and older 
adults in accurately reporting dyspnea. Petersen, von Leupoldt, & Van den Bergh (2014) 
found that self-report of dyspnea is more highly correlated with biopsychosocial factors 
than actual physiological changes, concluding that dyspnea has subjective aspects similar 
to pain that need to be considered when assessing (p. 94). These physiological and 
psychological changes in aging are not fully understood, and studies are inconsistent 
(Petersen et al., 2014).     
Theoretical Framework: Self-Efficacy Theory 
 Care of the chronically dyspneic older adult is an on-going interaction between 
patient and nurse to mutually identify the severity of symptoms and to provide 
individualized care that is based on optimal assessment. Having discovered that 
comprehensive assessment of chronic dyspnea is endorsed in the literature as generally 
deficient in clinical healthcare, the decision was made to investigate nurse self-efficacy 
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related to assessment of chronic dyspnea. Therefore, Bandura’s theory of self-efficacy 
(1977) was chosen as the theoretical model for this capstone.  
 Self-efficacy (SE) is a concept first developed and described by Albert Bandura 
(1977) to explain and predict behavioral change. “Perceived self-efficacy is defined as 
people’s beliefs about their capabilities to produce designated levels of performance that 
exercise influence over events that affect their lives. Self-efficacy beliefs determine how 
people feel, think, motivate themselves and behave” (Bandura, 1994, p. 71). The author 
hypothesized, “Expectations of personal efficacy determine whether coping behavior will 
be initiated, how much effort will be expended, and how long it will be sustained in the 
face of obstacles and aversive experiences” (Bandura, 1977, p. 191). 
A foundational concept of SE is that while cognitive processes can and do 
mediate behavioral change, mastery evolves best through effective performance. Four 
principle sources of information lead to SE: performance accomplishments, vicarious 
experience, verbal/social persuasion, and physiological states (Bandura, 1977, p. 191). 
Performance accomplishment is essentially practice that leads to the accumulation of 
experience and skills (Shortridge-Baggett, 2002), and is the most influential of the four 
information sources (Bandura, 1977). Vicarious experience is observation of desired 
behavior in similar others, and can influence the observer to believe that successful 
capability and mastery are possible for her/him. Verbal/social persuasion is the receipt of 
positive encouragement and/or reinforcement of expected behaviors from respected 
mentors or co-workers. Self-appraisal is the judgment of one’s own capabilities through 
internal cues. Feedback is received through personal physiological and psychological 
responses (Shortridge-Baggett, 2002). The four information sources would suggest that 
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through the introduction and use of a clinical assessment tool, nurses in the chosen 
capstone practice site would have the opportunity to increase self-efficacy. Hence, 
Bandura’s SE Theory underpins the design of this capstone (see Appendix A). 
Self-efficacy is often operationalized in SE scales as a subject’s “confidence” in 
his/her ability to perform specific tasks or impact behaviors. “Confidence” is considered 
to be an appropriate modifier for questionnaires (Sheer, 2014, p. 88). Therefore, the use 
of the term “confidence in” is used in the pre and post-test questions related to nurse self-
efficacy in this capstone. However, it is important to understand that self-efficacy and 
self-confidence are not synonymous (Lorenz, Gregory, & Davis, 2000, p. 183).  
Literature Review 
The evidence of impaired symptom recognition/reporting and altered sleeping 
posture in elders with chronic dyspnea, limited application of evidence based practice by 
home care nurses, and the high general and local site prevalence of chronic dyspnea 
clearly warrant improvements in nursing practice related to dyspnea assessment. A 
review of the literature to determine the most effective strategies to address or impact 
nursing practice related to self-efficacy of dyspnea assessment, as well as the most 
appropriate clinical dyspnea assessment tool was conducted.  
Description of Search Strategies 
 Numerous keywords were used to search the literature: dyspnea, dyspnoea, 
breathlessness, assessment, instrument, tool, scale, questionnaire, nurse, recliner sleep, 
chair, reclining sleep, and sleep posture. The search was limited to English language 
publications and human subjects. PubMed, CINAHL, and Google Scholar were the main 
databases utilized. All retrieved materials were extensively hand-searched. Where an 
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author was noted to have published several pieces of relevant literature, a SCOPUS 
search was conducted. 
Clinical Practice Guidelines 
One evidence-based nursing plan of care for the assessment, planning, 
intervention, and evaluation for dyspnea was discovered (Spector et al., 2007). The plan 
includes ten elements, including that dyspnea should be assessed from the patient’s 
perspective whenever possible via an assessment instrument (Level V evidence). Dyspnea 
assessment should include: quality and timing of dyspnea; alleviating and precipitating 
factors; associated symptoms; physical assessment and pulmonary function measures as 
indicated; pulmonary factors such as hypoxia or increased work of breathing; and non-
pulmonary factors such as pain, anxiety, depression, and fluid overload (p. 53).  
No clinical practice guideline (CPG) specific for dyspnea currently exists in the 
National Guideline Clearinghouse, but a comparable guideline and supplement for COPD 
was discovered. The CPG recommendations are:  
Recommendation 1.0 - Nurses will acknowledge and accept the patients' self-report of 
dyspnea (Level of Evidence = IV). 
Recommendation 1.1 (updated 2010) - All individuals should be assessed; assessment 
should include: 1) Level of dyspnea - If able to self-report, measure using a quantitative 
scale such as a visual analogue or numeric rating scale. If unable to self-report, present 
level of dyspnea should be measured using a quantitative scale such as the Respiratory 
Distress Observation Scale (RDOS); 2) Usual level of dyspnea – Use a quantitative scale 
such as the Medical Research Council Dyspnea Scale; 3) Vital signs, pulse oximetry, 
chest auscultation, chest shape, movement, and abnormalities, peripheral edema, 
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accessory muscle use; 4) Presence of cough/sputum; 5) Ability to complete a full 
sentence; 6) Level of consciousness; and 7) Swallowing difficulties (Level of Evidence = 
IV; Registered Nurses' Association of Ontario [RNAO], 2010). 
Nurse Self-Efficacy 
 An exhaustive literature review revealed voluminous information focused on 
nursing student and patient-focused populations related to self-efficacy. However, only 
six relevant studies were identified related to SE in practicing nurses (Fry, MacGregor, 
Hyland, Payne, & Chenoweth, 2015; Fry & MacGregor, 2014; Johnson, Hong, Groth, & 
Parker, 2010; Manojlovich, 2005; Welsh, 2014; Winslow, DeGuzman, Kulbok, & 
Jackson, 2014). The literature demonstrated that SE is a positive mediator in professional 
practice behaviors (Manojlovich, 2005), competency (Welsh, 2014), and clinical 
decision-making (Fry & MacGregor, 2014). Self-efficacy is a critical attribute in quality, 
compassionate clinical care, and important for the acquisition of skill and knowledge (Fry 
et al., 2015). There is a demonstrated association between learning and development in 
practicing nurses and work attitudes and performance (Johnson et al., 2010). 
Additionally, nurses who pursue academic advancement beyond initial preparation have 
higher SE, but not at the level of statistical significance (Winslow et al., 2014).  
Manojlovich (2005) theorized that SE would positively impact nursing practice 
behaviors by interacting with nursing leadership and structural empowerment to move 
practice toward more professional and less task focused behavior. The author surveyed 
500 Michigan nurses, with a 73% return rate, finding that structural empowerment 
contributed to professional practice behaviors indirectly through self-efficacy. The author 
concluded that if partially mediated through SE, professional nursing practice might 
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improve when the environment offers nurses opportunities and power through resources, 
support, and information (p. 271). Johnson and colleagues (2010) conducted a 
correlational survey of 404 nurses “at all grades and teams” (p. 612), and demonstrated 
that nurses with role-breadth self-efficacy (the perceived capacity to perform a broad 
range of roles) were more likely to have higher clinical performance and work attitudes 
(p. 609). 
In a multicenter study of 52 participant emergency room nurses, Fry & 
MacGregor (2014) found SE to be an important factor in clinical decision-making, 
recommending educational strategies to support self-confidence (tested as self-efficacy) 
and resilience (p. 91). Further, Fry and coworkers (2015) followed-up with a study of 80 
emergency department nurses in multiple centers, demonstrating that SE was gained 
through “nursing praxis”, defined as the sum of nursing experiences (p. 1623). The 
authors concluded that nursing experience, self-efficacy, confidence, and personal 
relationships were reflexive in that they were acquired as a result of practice and are 
important enablers of appropriate, timely and compassionate care (p. 1628).  
Welsh (2014) concluded that although nurse self-efficacy is an important 
characteristic of general nursing competency, literature is currently limited. With the aim 
of a developing a greater understanding of practice ability and skill enhancement, the 
author developed and tested a 16-item Nursing Care Self-Efficacy Scale  (NCSES) that 
demonstrated early validity and reliability. Germane to the question of nurse self-efficacy 
related to assessment of chronic dyspnea assessment explored in this capstone, Welsh 
notes that her NCSES instrument is meant to measure SE with respect to the five 
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fundamental components of the nursing process (assessment, diagnosis, planning, 
implementation, and evaluation), the first of which is assessment (Welsh, 2014, p. 374).  
Inadequate Dyspnea Assessment 
 
 Numerous authors concluded that the assessment of dyspnea is inadequate and 
use of validated measures of dyspnea are lacking (Jones, Price, & van der Molen, 2011; 
Mahler et al., 2010; Parshall et al., 2012; Yorke & Savin, 2010; Yorke, Moosavi, 
Shuldham, & Jones, 2010). Researchers agreed that conventional measures of respiratory 
function such as spirometry and peak flow in COPD and brain natriuretic peptide and 
arterial blood gasses in HF do not correlate well with dyspnea and the associated impact 
on quality of life (Crisafulli & Clini, 2010; Parshall et al., 2012; van der Molen et al., 
2013). Improved management requires a combination of assessments that include 
physical function, exacerbation history, and impact on overall functional status. Socrates 
& Mebazaa (2009) endorsed that tools can be utilized to measure dyspnea regardless of 
the underlying etiology (p. 639).  Numerous authors concluded that there is not enough 
current evidence to recommend any specific measurement tool (Bausewein et al., 2006; 
Jones, Miravitlles, van der Molen, & Kulich, 2012; Mularski et al., 2010; Weldam, 
Schuurmans, Liu, & Lammers, 2013); neither the ATS nor ACCP Consensus Statements 
recommended a particular instrument (Mahler et al., 2010; Parshall et al., 2012).  
There is emerging evidence that a short patient-reported questionnaire format may 
be the most reliable way to measure chronic dyspnea in the clinical setting (Jones et al., 
2011; Jones et al., 2012; Mahler et al., 2010; Yorke & Savin, 2010). To fully characterize 
disease burden, patient-reported outcomes should be followed independent to physical 
outcomes (Oga et al., 2007). A structured review of respiratory questionnaires concluded: 
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“Patient-reported outcome measures (PROMs) offer enormous potential to improve the 
quality and results of health services. They provide validated evidence of health from the 
point of view of the user or patient” (Davies, Gibbons, & Fitzpatrick, 2009, p. 3).  
Dyspnea Assessment Instruments   
 Historically, dyspnea has been assessed either directly through single item scales 
in patients at rest or during varying types of exercise or levels of exertion, and indirectly 
through queries of activities that are impaired due to breathlessness or impact of 
symptoms on quality of life. Direct measures do not capture the complexity of dyspnea, 
and indirect measures do not measure intensity of dyspnea itself, but rather are measuring 
the impact of dyspnea on physical activity, function, or quality of life (Yorke et al., 2010, 
p. 21). Also, the majority of tools were developed and validated only for use in COPD or 
for use in research rather than clinical practice (Bausewein et al., 2006; Jones et al., 2012; 
Yorke & Savin, 2010).  
 One systematic review (SR) of measurement instruments for breathlessness in 
clinical care was discovered. Bausewein and colleagues (2006) identified 33 dyspnea 
assessment instruments meeting inclusion criteria. A summary of their comprehensive 
findings is as follows: 
• No one tool is comprehensive enough. Combining a unidimensional (e. g. Visual 
Analog Scale) tool and disease-specific or multidimensional tool (Chronic 
Respiratory Disease Questionnaire) is recommended (pp. 399-400).  
• A lack of universal definition of breathlessness or dyspnoea (sic) hinders analysis 
and comparison of instruments (p. 406). 
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• Most instruments were developed for COPD, with some tested in healthy 
individuals. Validated tools include 6/11 in respiratory disease, 1/11 in HF, and  
3/11 in cancer (p. 403) 
• Six are self-administered, three are interviewer or computer completed, and two 
are mixed (p. 403).  
• Of the 33 instruments reviewed, the following were measured: severity (25), 
frequency (10), distress (7), intensity (4), associated symptoms (17), functional 
status questions (28), psychological dimensions (15), social dimensions (13), 
spiritual dimensions (0), and palliative care in malignant disease (4; p. 406).  
Refer to Appendix B for a more complete summary of the specific instruments.  
(Note that the Dyspnoea-12 instrument was published after this 2006 SR was published. 
Jones and colleagues (2012) acclaim the Dyspnoea-12 as “a novel approach” with 
importance “yet to be established” [p. 701]).  
Dyspnoea-12 Questionnaire 
The Dyspnoea-12 Questionnaire (Yorke et al., 2010) was chosen for this capstone 
because it has been validated in multiple diagnoses, is patient self-reported, is short and 
quick enough to be appropriate for clinical use, is not limited to measuring dyspnea 
against an index activity, and demonstrates adequate sensitivity to appreciate changes in 
intensity and severity (Yorke et al., 2010). The Dyspnoea-12 Questionnaire (D-12) is a 
12-item measure of the severity of dyspnea in physical and affective domains. Each 
question is assigned a patient-reported value on a 0-3 scale of “check this none” = 0, 
“mild” = 1, “moderate” = 2, or “severe” = 3 for a possible score of 0 (least dyspnea) to 36 
(most dyspnea).    
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Yorke and colleagues (2010), a team of two PhD nurses, an exercise physiologist, 
and a pulmonologist physician developed the D-12. Through an extensive English 
language literature review, the researchers identified 81 descriptors of dyspnea and 
breathlessness. These 81 descriptors were then validated in patients with COPD, HF and 
interstitial lung disease, statistically analyzed, and distilled down to 12 descriptor phrases 
in two categories: physical and affective. The tool has since been validated in asthma and 
pulmonary hypertension, and is currently being translated into other languages (Yorke, & 
Savin, 2010; Yorke et al., 2010; Yorke & Armstrong, 2014). 
Project Purpose 
The purpose of this DNP capstone was to investigate whether the use of a patient 
self-reported dyspnea assessment questionnaire would improve nurse self-efficacy related 
to dyspnea assessment. The project surveyed the self-efficacy and satisfaction of Site 
nurses related to dyspnea assessment before and after a two-month period of using the 
validated Dyspnoea-12 Questionnaire (Yorke et al., 2010) during patient visits. For 
purposes of the capstone, the complete unaltered Dyspnea-12 Questionnaire served as the 
first section of the assessment tool. For the capstone study instrument, a second section 
was added to assess for recliner sleeping behavior. This final 2-part assessment tool will 
be referred to as the “Dyspnea-12 with modifications” (mD-12), and this language is used 
throughout the remainder of the paper. The mD-12 (see Appendix C) was formatted for 
use as a clinical template, and was envisioned as being embedded into the electronic 
medical record (EHR) to promote nurse efficiency, ease of use, and documentation.  
Based on the one-group pre/post-test design of the capstone, the survey 
instruments were developed based on extensive literature review of Bandura’s published 
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materials on self-efficacy (Bandura, 1977; Bandura, 2006; Sheer, 2014) and the primary 
investigator’s experience with chronically dyspneic patients. The pre-test and post-test 
instruments can be found in Appendices D and E respectively. Other topics investigated 
were: nurse opinion of the template and process, rate of template utilization, and inpatient 
admission rate for cardiorespiratory related conditions during the period of clinical 
template use.  
Capstone Goals and Objectives 
1. To improve nurse self-efficacy related to assessment of chronic dyspnea in older 
adults. 
a. At least 90% of the nurse study group will demonstrate improved self-
efficacy scores on the post-test survey immediately following the data 
collection phase (13 March 2015).  
b. At least 85% of the nurse study group will demonstrate satisfaction with the 
clinical template based on qualitative responses to the post-test survey (16 
March 2015).  
2. To improve management of chronic dyspnea in community-dwelling older adults. 
a. By the end of the data collection phase (13 March 2015), at least 90% of 
patient visits will have dyspnea assessed utilizing the dyspnea clinical 
template.  
b. During the two-month data collection phase while the clinical template is in 
use, total inpatient admissions for cardiorespiratory related conditions will 
drop at least 5% from baseline (32% of total admissions) for Site patients. 
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Design and Methods 
 
Ethics and Protection of Human Subjects  
 
The University of North Dakota (UND) Internal Review Board granted ethics 
approval for the capstone as an exempt research study.  The primary investigator’s Site 
organization Nursing Evidence Based Practice (EBP) Work Group granted approval as an 
EBP project exempt from Internal Review Board (IRB) procedures. No consent forms 
were required by either body, as completion of pre-test and post-test forms served as 
implied consent. No compensation was provided. Confidentiality and privacy were 
assured to subjects at outset, and maintained through storage on internally encrypted 
computer spreadsheets or locked in the main investigator’s office. Due to UND IRB 
requirements, data will be maintained for three years and then destroyed in compliance 
with stringent internal Site policies. Further, in order to safeguard the anonymity of a very 
small study group, no demographic data was gathered. The elderly adults whom the 
nurses assessed during the capstone were a potentially vulnerable population, but 
enjoy(ed) rigorous site-specific safeguards and oversight during the study period through 
three years of required storage.  
Setting and Organization  
This DNP capstone was conducted within an outpatient department where 
primary care is delivered in the place of residence to a cohort of 140-150 majority older 
adults with chronic illness. The full interdisciplinary team of 25 included a nurse program 
director, two part time physicians, three certified nurse practitioners, nine registered 
nurses, two clinical pharmacists, two social workers, and one each: psychologist, physical 
therapist, occupational therapist, physical therapy assistant, and registered dietician.  
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The setting was an outpatient department of a governmental healthcare 
organization that resides in a Western United States city of 300,000 and provides 
healthcare services to 94,000 individuals on an annual budget of $160 million. A staff of 
980 supports an on-site outpatient department, a 46-bed secondary care hospital, an 11-
bed in-patient substance abuse ward, and a 28-bed skilled nursing facility (SNF) with 8-
bed hospice unit, and three community outpatient clinics at a distance from the main 
campus. The organization delivers 10,995 acute care visits, 6,659 SNF bed days of care, 
and 213,565 ambulatory care visits annually. The umbrella organization of the local Site 
employs a total of 243 RNs. 
Population Description 
 The study population was registered nurses and nurse practitioners employed 
within an outpatient department providing primary care in the place of residence to a 
cohort of 140-150 majority older adults with chronic disease. For the purposes of this 
project, nurse was defined as a registered nurse (RN) or Nurse Practitioner (NP) 
employed at the Site, including nine RNs and two NPs (in addition to the primary 
investigator). Because the Site had a small staff, a decision was made to include all nurses 
irrespective of level of education or practice in order to boost the capstone sample size. In 
the Site, 77.7% (7 of 9) RNs hold bachelor’s degrees and 22% (2 of 9) hold master’s 
degrees. In terms of gender, two (22%) of the Site nurses are male. All Site RNs are 
Caucasian and aged 46 years or younger.  
Design 
The capstone design was a one group pre and post-test design (Issel & Handler, 
2013) to measure nurse self-efficacy related to assessment of chronic dyspnea. The study 
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population was drawn from a purposive convenience sample of available RN and NP 
staff at the Site who were analyzed as a group through anonymous unmatched pre-test 
and post-test surveys in order to meet expedited UND and Site IRB constraints. This 
design was chosen for its straightforward applicability to evidence based practice, and 
accessibility to a targeted nurse/older adult population. The design included quantitative 
analysis to investigate nurse satisfaction with the template, ideas for revision, and clinical 
practice improvements that may result from participation in the study. All Site RNs (9) 
and NPs (2) were invited to participate voluntarily. Data collection was conducted for 
nine weeks.  
Subjects were asked to use the Dyspnea-12 Questionnaire with additional 
questions to assess for sleeping posture during all patient visits and document each 
assessment in the electronic health record (EHR) template. The complete unaltered D-12 
Questionnaire served as the first section of the capstone assessment tool. A second 
section was added to assess for recliner sleeping behavior. The final 2-part assessment is 
referred to as the D-12 with modifications, or mD-12. While the terminology 
“modifications” and “modified” is utilized here, it is important understand that the 
validated D-12 instrument itself was not modified in any way. The two-part mD-12 was 
formatted for use as a clinical template, and was envisioned as being embedded into the 
EHR for efficiency and ease of use by the nurses (see Appendix C).  
Anticipated results of the capstone included improved nurse self-efficacy related 
to dyspnea assessment, as well as quantitative and qualitative nurse satisfaction with the 
mD-12 instrument, and improved assessment of chronic dyspnea in community-dwelling 
older adults. Secondary outcomes that were considered, but were beyond the scope of the 
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capstone intervention were: potentially fewer emergency department episodes and 
inpatient admissions for respiratory exacerbations and associated reduction in healthcare 
costs, improved nursing articulation, documentation, and clinical decision-making related 
to chronic dyspnea, and improved management of patients with chronic dyspnea. 
Data Analysis and Interpretation 
 
Sampling and Data Collection 
The project was initiated on January 12, 2015 with a classroom-based session for 
nurses in the department, a total of nine registered nurses and two certified nurse 
practitioners (see capstone timeline Appendix F). The main investigator conducted the 
session. The agenda included an explanation of the study, rights to accept or decline 
participation, and assurance of participant understanding prior to beginning the study. 
The pre-test was administered, the nurses were given a copy of the assessment template, 
its use was explained, and questions answered. Template use during patient visits began 
the day of the session and pre-test. Nurse and NP subjects were asked to assess dyspnea 
with the template at each nursing visit during the subsequent two months. Because the 
standard method of documentation for Site staff is to take hand-written notes while in the 
home, and transfer them into the computerized medical record following the visit, the 
subjects used a paper copy of the template during assessment of the patients, and then 
transferred the information into the EHR. In compliance with UND and Site IRBs, paper 
copies were given to the main investigator anonymously; the copies were counted and 
destroyed. After nine weeks of template use, the post-test was administered on March 16, 
2015, followed by a discussion of nurse subjects’ opinion of the template and 
implications for practice.  
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Analysis  
The Site Program Director provided the main investigator with a report of the 
total number of patient visits, rate of associated template usage, and in-patient admission 
count with diagnosis. The template completion and visit reports were provided as a list of 
RN or NP subjects. Therefore, it was possible to perform separate analyses of the RN and 
NP groups. The results of the pre-test and post-test self-efficacy Likert-type questions (1 
through 6) were each examined for trend identification and statistical analysis; remaining 
qualitative queries were compiled and analyzed. 
Template Use and Completion 
 Nine RNs and one NP completed the study. Nine RNs and 2NPs took the pretest. 
The second NP had zero template utilization, opted out of the post-test, and was therefore 
excluded from the data analysis as a non-participant. During the nine-week data 
collection period, the participating RN/NP group conducted a total of 368 visits, ranging 
from an individual subject low completion of 1 visit to an individual subject high 
completion of 59 visits. The template completion mean was 43.91%, standard deviation 
31.58%, and range was 0.0% to 90.2% of the visits for the ten participating subjects. 
Lower visit utilization was directly correlated with markedly lower template 
completion in three subjects (see Appendix G, Tables G1 and G2). There was no 
significant change in acute care admission rate related to cardiorespiratory diagnoses 
(33.3% versus 30.1% respectively) for the study period compared with calendar year 
2014 (see Appendix G, Table G3). In spite of the small sample size (n = 10), the Shapiro-
Wilk test confirmed that the data are normally distributed (p > .05; see Appendix H for 
statistical analyses) 
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Self-Efficacy Pre-Test/Post-Test Comparison 
The purpose of the first six questions on the pre-test and post-test (SE-6) was to 
measure the change in nurse self-efficacy with respect to: assessing dyspnea in general, in 
familiar and unfamiliar patients, making sound clinical decisions about, accurately 
documenting, and articulating changes related to dyspnea. For consistency, the SE-6 
questions on the pre-test were exactly duplicated on the post-test. Each was a 5-point 
Likert-style question, where nurses’ choice of responses ranged from “Strongly Agree” 
(quantitatively, “5”) to “Strongly Disagree” (quantitatively, “1”). The distribution of 
responses is displayed in Appendix G, Table G4.   
Participant responses for the SE-6 were dichotomized into either “Strongly 
Agree” (SA) or “not Strongly Agree” (n-SA) with an a priori prediction that the number 
of post-test “Strongly Agree” responses out of all 300 possible responses for that test 
would be greater than all 300 possible responses of the pre-test. A chi-Square Test-of-
Independence analysis was performed to determine association between SA (higher 
efficacy) and n-SA (lower efficacy) before and after the period of patient assessment with 
the mD-12 template (intervention). All expected cell frequencies were greater than five. 
There was a statistically significant association between an increase in self-efficacy 
related to dyspnea assessment as measured by SA responses and n-SA by nurses before 
and after using the mD-12 instrument for patient assessment, χ2 (1) = 7.054 (p = .008; See 
Appendix H; Tables H1 through H12). There was a small association (effect size) 
between improved self-efficacy and template use, φ = 0.108, (p = .008). That is, nurses 
were 7.4 times more likely to respond “Strongly Agree” after the intervention than 
before. 
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Qualitative Data 
 The capstone pre-test questions 7 through 10 and post-test questions 13 through 
19 gathered qualitative responses related to dyspnea assessment and template use. No 
formalized method was applied for analysis. Subject responses are listed verbatim for the 
pre and post-tests in Appendices I and J, respectively, and summarized as follows: 
• Use the mD-12 with associated diagnoses, in patients with existing chronic dyspnea, 
or with initial or quarterly assessments. It is not appropriate for universal use. 
• Shorten or simplify the tool; revise the scale to account for at rest versus with 
activity; revise “none, mild, moderate, or severe” to “never, rarely, sometimes, or 
frequently”. 
• The Questionnaire is helpful to encourage patient discussion, better identify degree of 
dyspnea and emphasize the importance of assessing for sleeping posture. 
• Nurses generally valued having a more thorough set of queries to intensify patient 
assessment and reported that chronically dyspneic patients also appreciated the 
approach and questionnaire. Some patients not dyspneic were frustrated/impatient 
with the assessment. 
• Nurses who would choose to use the tool in the future were mixed:   
o No (n = 3) – “can assess without it, too difficult for the patient or want to qualify 
answers/tell stories, did not learn anything new.”  
o Yes (n =4) – “helpful in ‘pulling’ answers from patients; one subject wrote, “Yes: 
I learned more about dyspnea in my patients. I didn’t know how short of breath 
some of them really are.” 
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o Yes, with changes (n = 3) – “only with patients who actually have dyspnea… 
would modify, and use for initial assessment and change in condition.” 
• Nurses cited a majority of the dyspnea assessment elements that are included in the 
Clinical Practice Guideline (RNAO, 2010), implying that they were well-educated 
and well-informed clinicians prior to the pre-test and information session. 
Summary Discussion and Interpretation 
Nine RNs and one NP completed the study, with a total RN mD-12 template 
usage of 59.06% (189/320 visits); NP usage was low at 16.67% (8/48) of participating 
NP visits during the study period. Overall total RN/NP mD-12 template usage was 
53.53% (197/368 visits). There was no demonstrated change in acute admission for 
cardiorespiratory diagnoses during the study period, compared with the previous year. In 
spite of its limitations of small sample size and low powered design, this capstone has 
demonstrated improved nurse self-efficacy related to mD-12 template use as measured by 
an increase in “Strongly Agree” in the six questions related to assessment of chronic 
dyspnea, and a statistically significant change in chi-square test-of-independence (p = 
.008; effect size φ = 0.108) for the study group. Nurse satisfaction with the mD-12 and 
embedded template appeared to correlate in both positive and negative directions with 
targeted patient status. That is, nurses deemed the mD-12 satisfactory if the patient being 
assessed had chronic dyspnea or a known cardiorespiratory diagnosis, and less 
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Strengths and Limitations 
 Threats to Internal Validity 
Notable threats to internal validity in this capstone were attrition, maturation, 
diffusion (Kirchhoff, 2009, pp. 122-127), and testing (Pollit & Beck, 2012, p. 246).   
• Attrition: There was substantial attrition during the study period. Participation of the 
two NPs was negligible. NP “A” made 42 visits during the study period, did not 
assess with the template at any of the visits or take the post-test, and was therefore 
excluded from the total participation count. NP “B” completed pre and post-tests, 
completed 8/48 visits, but was retained in the total sample. The total study visit 
number prior to exclusion of NP “A” was 410, and after exclusion was 368. 
Therefore, NP template completion was 8/368 or 2.17% (versus 8/410 [1.95%] 
counting all visits during the data collection period).  
• Maturation: As the data collection period progressed, some subjects’ template 
completion became inconsistent. Post-study, subjects commented that there was 
greater willingness to use the mD-12 with patients who had dyspnea, but considered 
its use with every patient inappropriate. While this element led to lower visit 
assessment completion, it may also be an empirical indicator of growing self-efficacy: 
Were nurses making an independent clinical judgment of whether or not to assess 
with the mD-12 based on patient diagnosis, status, and experience with the tool?  
• Diffusion – Interaction among subjects was noted to occur informally throughout the 
data collection period, and may have affected responses. In spite of requesting that 
the nurses not discuss the study with each other until completion of the data collection 
period, the small staff size, nature of office setting, and interpersonal interactions 
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rendered this request unreasonable. However, given the capstone design, diffusion 
may have served serendipitously as a “vicarious experience” among nurse subjects to 
positively influence self-efficacy.  
• Testing – Subject familiarity with a testing instrument or questions can enhance 
performance. “It has been found, particularly in studies dealing with attitudes, that the 
mere act of collecting data from people changes them” (Pollit & Beck, 2012 p. 246).  
In this study, simply attending the information session and taking the pre-test could 
have impacted nurse responses on the post-test.  
Template Not Embedded  
  The less than anticipated template completion rate (original goal of 90% versus 
actual of 53.5%) is likely directly related to reversal of an important design element. 
Initial approval had been given to embed the template within the nursing note, but was 
reversed prior to starting data collection. Therefore, to document the assessment in the 
EHR, subjects were required to take several extra steps to open and load the template. A 
majority of the nurses endorsed this as a significant barrier related to low completion 
numbers because they either forgot or did not have enough time to complete the 
documentation. Several subjects verbalized that had the tool been embedded within the 
nursing note, they would have been cued to conduct the assessment more consistently.  
  The mixed survey response about ease of use of the template/assessment may 
have also been directly related to the data collection design. Had it been possible to 
document the assessment directly into the EHR at the time of patient visit, completion 
numbers and nurse satisfaction may have shown more positive results. Other negatives 
associated with low completion numbers were that nurses found the assessment 
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inappropriate for patients who did not have chronic dyspnea, patients attempted to 
quantify their answers based on during activity versus at rest, and subjects found the tool 
too long during a busy clinical day.  
Limited Time Period 
 This capstone was limited by a short time period. Data collection took place from 
January through March 2015. A longer time period would allow a repeated (matched 
measures) design or direct patient study group design. This capstone project demonstrates 
the preliminary study of an important practice problem of notable clinical significance 
with great potential for further study.  
Cognitive Impairment 
 Patient self-reported assessment instruments such as the D-12 and mD-12 have 
limited usefulness in patients with moderate to severe cognitive impairment. This is an 
important limitation of the capstone because the prevalence of cognitive impairment is 
approximately 6-10% at age 65 and increases with age (Chapman, Williams, Strine, 
Anda, & Moore, 2006). Therefore, alternative means of assessing breathlessness in 
cognitively impaired older adults will require future consideration and research. 
Implications and Future Directions 
 The capstone has demonstrated two key findings. First, nurse self-efficacy related 
to chronic dyspnea assessment improved after two months’ use of a validated patient self-
reported questionnaire, the modified D-12. After using the mD-12, nurses in this study 
group were significantly more confident in assessing, documenting, articulating, and 
making clinical decisions about chronically dyspneic patients. Nurses verbalized partial 
satisfaction with the mD-12, recommending best application for initial assessments, to 
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assess for dyspnea-related recliner sleep behavior, and in patients with cardiorespiratory 
related diagnoses, but not universally. These findings are preliminary, and will require 
replication in larger cohorts and varied clinical settings, but are a pilot demonstration of 
clinical effectiveness.  As such, the capstone reflects the preliminary study of an 
important practice problem of notable clinical significance with great potential for further 
study. 
 The mD-12 remains available as a clinical template within the Site EHR that RN 
or NP staff can access and use at any time. There is on-going discussion about the 
possibility of adding the questionnaire or a streamlined version to required initial and 
quarterly patient assessments, and for use as a telephone triage tool. Site staff has also 
recommended that caregivers be educated to use the mD-12 questions with patients. 
 Particular future research is recommended with the mD-12 in telephone triage of 
chronically dyspneic patients. The quantifiable elements within the mD-12 related to the 
physical and affective domains of dyspnea could be beneficial to clinical staff attempting 
to make a decision about the urgency of changes in patient condition. An acute escalation 
in the mD-12 score could help guide medication management, need for emergent versus 
non-emergent services, and patient education. Given that older adults often under-report 
or misinterpret changes, the mD-12 also has the potential for use in patient self-
management, as chronically dyspneic adults (if cognitively intact) could be taught to self-
administer the tool. This is also a potential opportunity for future study that could 
ultimately lead to clinical usefulness. 
 Future study using the mD-12 as a research tool to measure direct patient 
outcomes in larger cohorts of older adults in other healthcare settings, in patients with 
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specific related diagnoses, and in younger adults is recommended. Specifically, study of 
older adults with the mD-12 is recommended in outpatient, acute care, emergency 
department, cardiac and pulmonary rehabilitation, skilled nursing facility, and in 
palliative care and hospice. Given the dearth of existing literature, future research of 
recliner sleep behavior using the mD-12 is highly recommended. Further study of 
assessment self-efficacy in practicing nurses is also recommended. Future research could 
include a nurse or NP study group with repeated (matched) measures, or a direct patient 
study group. 
Potential Cost Efficiency  
 If used purposefully to assess patients with cardiorespiratory conditions or 
symptoms, the mD-12 could potentially improve clinical care and cost efficiency in 
varied settings of care with elderly adults including reduced ambulatory care and nurse 
home visits. Improved recognition of worsening dyspnea, leading to quicker treatment of 
less serious exacerbations, fewer emergency episodes, fewer preventable acute care 
admissions and readmissions, and improved management over time could each 
potentially lead to significant cost avoidance. Again, the brevity and numerical scale of 
the tool could be easily and inexpensively adapted for use in nurse telephone triage to 
quantitate patient changes, and enhance the articulation, clinical decision-making, and 
documentation of dyspnea.  
Conclusion 
Bausewein, Booth, & Higginson (2008) state the following about dyspnea in 
advanced disease: “Regular, standardized assessment of the severity of this distressing 
symptom is not yet considered mandatory in clinical practice, yet without this there can 
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be no accurate assessment of the effectiveness of interventions and necessary changes of 
treatment” (p. 95). Nursing assessment of chronic dyspnea in the older adult population is 
clearly an important issue that calls for creative strategies and clinical improvement. An 
introductory session and associated use of a clinical template based on patient self-
reported outcome measures was aimed at increasing nurse self-efficacy and concomitant 
improved practice quality. The overall purpose of this capstone was to increase dyspnea 
assessment-related self-efficacy in nurses caring for older adults with chronic dyspnea, to 
identify a tool acceptable to nurses for assessing dyspnea in clinical practice, and to 
improve assessment of chronic dyspnea in community-dwelling older adults.  
 In summary, the capstone addressed the problem of inadequate dyspnea 
assessment of older adults in the home care setting. The literature confirms that chronic 
dyspnea is a potent, independent predictor of mortality and is prevalent in older adults, 
yet the assessment of dyspnea is insufficient and use of validated measures is inadequate. 
Older adults either under-report or have poor perception of chronic dyspnea, developing 
strategies (such as sleep in upright postures) that self-restrict daily activities in order to 
improve breathing and quality of life. Gaps in care currently exist in the study setting 
where chronic dyspnea-related diagnoses result in 32% of inpatient admissions, but 
nurses do not use a validated dyspnea assessment instrument. The ATS and ACCP 
recommend complete assessment of dyspnea via physical and affective domains to 
improve early recognition of dyspnea exacerbation. Emerging evidence indicates that a 
short patient-reported outcome questionnaire format may be the most reliable way to 
measure chronic dyspnea in the clinical setting.  
NURSE SELF-EFFICACY AND CHRONIC DYSPNEA ASSESSMENT                 34 
“People who regard themselves as highly efficacious act, think, and feel 
differently from those who perceive themselves as inefficacious. They produce 
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Appendix B - Dyspnea Instruments by AHRQ Classification 
The literature revealed numerous, but inconsistent, means of classifying dyspnea assessment 
instruments. For the purposes of this review, the instrument classification outlined for an Agency for Health 
Research and Quality (AHRQ) Symposium on palliation of dyspnea was used. The AHRQ categories are: 
Intensity, Situational or Functional, Effect on Health-Related Quality of Life (HRQoL), and Qualitative 
Descriptors (Mularski et al., 2010). 
Intensity Rating Instruments are one-dimensional scales that seek to ask the patient to assign a number or 
quantity to the symptom of dyspnea at a singular moment in time. Examples are the Visual Analog Scale 
(VAS), Borg/Modified Borg Scale, and the Numeric Rating Scale (NRS). These instruments may be 
sufficiently sensitive for initial management. The VAS is used in clinical and research settings to measure 
intensity, but has weak reliability. It is similar to the 0/10 pain scale. It is most useful for within-subjects 
measures. The modified Borg Scale is a10-point scale of intensity developed to measure the rate of 
perceived exertion in healthy subjects, and now commonly used in COPD. It is more reproducible than 
VAS, is most sensitive in post-activity testing such as after pulmonary rehabilitation, but dyspnea ratings are 
not reproducible with physiologic indicators such as oximetry.  It has usefulness for phone assessment. The 
NRS is also a 0-10 scale of intensity, easy for patients to use, and correlates well with the VAS. It is more 
repeatable than VAS (Bausewein et al., 2006). 
Situational/Functional Instruments are multidimensional measures. The Medical Research Council 
Dyspnea Scale (MRC) is not sensitive enough to capture change after intervention, and not reliable in 
clinical practice. It is widely used to assess prevalence in epidemiological studies. The Oxygen Cost 
Diagram (OCD) is a retrospective measure of patient report of how dyspnea hinders daily activities. It 
correlates well with 6-minute walking test, but not pulmonary function tests. The Baseline Dyspnea 
Index/Transitional Dyspnea Index (BDI/TDI) is an interviewer-administered 5-category test of magnitude of 
task, magnitude of effort, and functional impairment. It is sensitive enough to capture acute change/COPD 
exacerbation and the TDI can trend changes from baseline condition.  
Health Related Quality of Life (HRQoL) Instruments are complex, comprehensive, lengthy and 
burdensome for patients in clinical care settings, but effective for research. There is good correlation with 
dyspnea intensity and HRQoL measures. The Chronic Respiratory Disease Questionnaire (CRQ) is the most 
widely used. However, it is COPD specific and not sensitive to small condition changes. The St. George 
Respiratory Questionnaire (SGRQ) is an interviewer supervised, comprehensive, 76-item scale specific to 
asthma, COPD, and bronchiectasis that takes15-25 minutes to complete, and is widely used in research 
(Bausewein et al., 2006).  
Qualitative Descriptors are verbal descriptors related to dyspnea intensity such as heavy/fast breathing and 
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Appendix C - Modified Dyspnoea-12 Assessment (mD-12) Template 
 
1. ☐ Nurse cannot assess due to cognitive impairment or alteration in mentation.   
 
2. Your provider and nurses are testing a new way of asking about your breathing. These questions are 
designed to help us learn more about your breathing. It will take less than 5 minutes.  
 
3. I will read each question, and then ask you to the best answer that matches your breathing “these days”.   
Then, I will ask you to answer each as none, mild, moderate, or severe. For example, the first statement is, 
“My breath does not go in all the way.” Answer none, mild, moderate, or severe. Do you have any 











 = 3 
Total 
 
  1    My breath does not go in all the way      
  2    My breathing requires more work      
  3    I feel short of breath      
  4    I have difficulty catching my breath      
  5    I cannot get enough air      
  6    My breathing is uncomfortable      
  7    My breathing is exhausting      
  8    My breathing makes me feel depressed      
  9    My breathing makes me feel miserable      
10    My breathing is distressing      
11    My breathing makes me agitated      
12    My breathing is irritating      
TOTAL      
Reproduced from: Quantification of dyspnoea using descriptors: Development and initial testing of the Dyspnoea-12 by J. 
Yorke, S. H. Moosavi, C. Shuldham, & P. W. Jones, Thorax, 65(1): 21-26, 2010. With permission from BMJ Publishing 
Group Ltd. 
 
4. Next, I will ask 3 questions about where you prefer to sleep and why. We want to do a better job at finding 








• A standard bed  
• A standard bed with my head elevated on:  
                                     * Pillows 
                                     * Other:  
• A hospital bed 
• A recliner chair 
                                   * With legs elevated 
                                   * With legs down 
• Other:  
#2 On most nights, how do you sleep?  
 
• Lying flat  
• Head elevated 
• Legs elevated  
• Other: 
The reason you sleep THIS WAY IS?  
Nurses: please document anything/all 
comments the patient says here.  
Drop-down menu: 
* I can breathe better 
* Other:  
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Appendix D - Pre-test for Dyspnea Assessment Project 
 
1. I am confident in assessing dyspnea. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree  ☐ Strongly disagree 
 
2. I am confident that I can assess dyspnea in patients I am familiar with.  
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree  ☐ Strongly disagree 
 
3. I am confident that I can assess dyspnea in patients that I am not familiar with.  
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree  ☐ Strongly disagree 
 
4. I am confident that I can make sound clinical decisions related to dyspnea. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree  ☐ Strongly disagree 
 
5. I am confident that I can accurately document dyspnea symptoms. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree  ☐ Strongly disagree 
 
6. I am confident that I can articulate changes in dyspnea that indicate 
improvement or worsening in a patient’s status. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree  ☐ Strongly disagree 
 
7. What method(s) do you use for assessing for dyspnea?      
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Appendix E - Post-test for Dyspnea Assessment Project 
 
1. I am confident in assessing dyspnea. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
2. I am confident that I can assess dyspnea in patients I am familiar with.  
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
3. I am confident that I can assess dyspnea in patients that I am not familiar with.  
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
4. I am confident that I can make sound clinical decisions related to dyspnea. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
5. I am confident that I can accurately document dyspnea symptoms. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
6. I am confident that I can articulate changes in dyspnea that indicate improvement or 
worsening in a patient’s status. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
7. I found the Dyspnoea-12 Questionnaire easy to use. 
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
8.   The Dyspnoea-12 Questionnaire was helpful in assessing my patients’ symptoms.  
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
9.   All questions on the Dyspnoea-12 tool were clearly stated for my patients.  
☐ Strongly agree   ☐ Agree   ☐ Neither agree nor disagree  ☐ Disagree   ☐ Strongly disagree 
 
10.    The template was helpful in understanding whether the patient’s sleeping preference 
was related to dyspnea.  
☐ Strongly agree.   ☐ Agree.   ☐ Neither agree nor disagree.  ☐ Disagree   ☐ Strongly disagree 
 
11.    Overall, the template was easy to use.  
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12. Please estimate how often you performed assessment with the Dyspnea-12 tool and 
entered it into the CPRS template:   
 
☐ about ¼ of the time (0-25% of my patient visits) 
☐ about ½ of the time (26-50% of my patient visits)   
☐ about ¾ of the time (51-75% of my patient visits)  
☐ always or most of the time (76-100% of my patient visits)   
 
13.    What was most helpful about using the template?  
 
 
14.    What was least helpful about using the template?  
 
 
15.    Would you use the template in the future?  Why or Why not? 
 
 
16.    What changes, if any, have you made in your method(s) for assessing dyspnea as a 
result of using this template?      
 
 
17.    Please share any comments or suggestions about the template. 
 
 
18.    Please share any comments or suggestions about conducting an assessment of a 
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Table G1 - Template Use All Subjects 
n = 10 Completed 
Visits 
Template 
Used % Use 
A 49 20 40.8 
B 1 0 0.0 
C 59 52 88.1 
D 46 22 47.8 
E 25 2 8.0 
F 11 3 27.3 
G 45 30 66.7 
H 43 23 53.5 
I 41 37 90.2 
J 48 8 16.7 
Total 368 197 53.5 
Table G3 
Admissions for Cardiorespiratory Conditions* 




Total Count   % 
CY 2014   126 39 30.1 
Q4 2014 39 13 33.3 
01-12-15 to 03-15-15 21  7 33.3 
C   *CHF, COPD (includes Bronchitis), Pneumonia, Pulmonary 

















































            Clinician 
Table G2 Self-Reported Template 
Usage: Q12 (n = 10) 
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Appendix H – Capstone Data Analysis Tables 
 
Table H1 SA Response Crosstabulation 
  Test Total 
Pre-Test Post-Test 
SA Response Strongly Agree Count 6 19 25 
Expected Count 12.5 12.5 25.0 
Not Strongly Agree Count 294 281 575 
Expected Count 287.5 287.5 575.0 
Total Count 300 300 600 
Expected Count 300.0 300.0 600.0 
 
  Table H2 chi-Square Test-of-Independence 







Pearson Chi-Square 7.054a 1 .008     
Continuity 
Correction 
6.010 1 .014     
Likelihood Ratio 7.397 1 .007     
Fisher's Exact 
Test 
      .013 .006 
Linear-by-Linear 
Association 
7.042 1 .008     
N of Valid Cases 600         
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 12.50. 
b. Computed only for a 2x2 table 
 
Table H3 Tests of Normality 
Test Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Strongly Agree = 5 Pre-Test .202 6 .200* .853 6 .167 
Post-Test .223 6 .200* .908 6 .421 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Table H4 Group Statistics  





Computed Pre-Test 6 5.00 4.472 1.826  
Post-Test 6 15.83 5.845 2.386  
 
 
 Table H5 Group Statistics 




Strongly Agree = 5 Pre-Test 6 1.00 .894 .365 
Post-Test 6 3.17 1.169 .477 
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Table H6 Correlations 
 Descriptive Statistics 
   Mean Std. Deviation N 
 Post-Strongly Agree 
= 5 
3.17 1.169 6 
 Pre-Strongly Agree 
= 5 
1.00 .894 6 
 
Table H7 Correlations 
  Post-Strongly 
Agree = 5 
Pre-Strongly Agree = 5 
Post-Strongly 
Agree = 5 
Pearson Correlation 1 .765 
Sig. (2-tailed)   .076 
N 6 6 
Pre-Strongly 
Agree = 5 
Pearson Correlation .765 1 
Sig. (2-tailed) .076   
N 6 6 
 
Table H8 Nonparametric Correlations 
 Post-
Strongly 
Agree = 5 
Pre-
Strongly 
Agree = 5 





Sig. (2-tailed)   .101 






Sig. (2-tailed) .101   
N 6 6 





Sig. (2-tailed)   .094 






Sig. (2-tailed) .094   
N 6 6 
 
 
Table H9 Symmetric Measures 




Phi -.108 .008 
Cramer's V .108 .008 
N of Valid Cases 600   
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Table H10 Mann-Whitney Test 
Test Statisticsa 
  Strongly Agree = 5 
Mann-Whitney U 2.000 








a. Grouping Variable: Test 
b. Not corrected for ties. 
 
Table H11 Independent Samples Test 
  Levene's Test for Equality of 
Variances 
t-test for Equality of Means 







Interval of the 
Difference 
Lower Upper 
Computed Equal variances 
assumed 
.432 .526 -3.606 10 .005 -10.833 3.005 -17.528 -4.139 
Equal variances not 
assumed 
    -3.606 9.360 .005 -10.833 3.005 -17.591 -4.076 
 
Table H12 Independent Samples Test 
  Levene's Test for Equality of 
Variances 
t-test for Equality of Means 







Interval of the 
Difference 
Lower Upper 
Strongly Agree = 5 Equal variances 
assumed 
.432 .526 -3.606 10 .005 -2.167 .601 -3.506 -.828 
Equal variances not 
assumed 
    -3.606 9.360 .005 -2.167 .601 -3.518 -.815 
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Appendix I - Pre-Test Qualitative Data 
 
QUALITATIVE 
Q7 Q8 Q9 Q10 
Method(s) for assessing dyspnea Challenges or barriers assessing dyspnea 
Challenges or barriers documenting 
dyspnea 
Challenges or barriers articulating 
dyspnea 
Observation, auscultation (with 
scope and "naked ears"), 
interview/verbal report by patient 
Patient's perception of dyspnea; 
patient's verbalization of their 
normal. 
? Team members on a "different page"--We're not using a standardized tool. 
Visual assessment, lung 
assessment. Questioning SOB with 
activity or just sitting. Ask if they 
sleep elevated. Use of inhalers 
Patients will deny SOB but then 
admit that they can't breathe lying 
down. 
Need to ask more questions than "Do 
you have any SOB?" Can't think of any. 
Auscultation of lung sounds, 
respiratory rate, O2 sats, SOB 
w/activity. Above w/ambulation 
Sometimes difficulty w/positioning 
in home or cooperation of patient 
(dementia). 
Sometimes unsure of specific 
terminology: i.e. different types of lung 
sounds 
Same as #9 
VS; oxygen monitor; history and 
current conditions Redo sats 
History of smoking; vocabulary related 
to lung sounds Common vocabulary 
Assess respiratory rate, work of 
breathing, or verbal response from 
patient. 
Patient has difficulty describing-
frequently respond with 
"sometimes" or "kind-of" 
No clear descriptors or guidelines. How 
do I know when an intervention is 
appropriate? There is no clear way to 
assess time frame - is this new? How 
long? 
It is unclear when to note changes. Is 
this information communicated only 
when the patient requires an 
intervention? When is this felt to be 
pertinent? When there is a change 
from patient's baseline? 
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Patients' report of dyspnea at rest 
or w/activity; respiratory rate, 
oxygen saturation, use of accessory 
muscles, ability to converse 
May not be familiar with patient's 
baseline. Patients do not always 
recognize changes in dyspnea or are 
reluctant to report changes. 
Consistency with providers and 
standards and quality of documentation. 
No consistent parameters. 
Knowing that the definition of terms 
used means the same thing. 
Color, nails, activity tolerance, 
talking, listening, looking, weight, 
when do they feel relief--meds, 
positional, stressors 
Patient denial; What's normal for 
patient. 
Unsure at this time. I chart what I have 
assessed. 
I know, but do have problems 
articulating…finding the right words 
sometimes. 
I ask patient about specific 
activities and positional changes. I 
ask what makes it worse, or better. 
I think some patients aren't always 
forthcoming and/or become 
comfortable with their baseline. 
Sometimes the patient has cognitive 
difficulties such as memory issues. 
Sometimes documentation can be too 
lengthy and time consuming. 
I can't think of any at the present 
moment. 
Resp rate, O2 sat, LPM oxygen 
up/down or same rate, WOB, 
patient self-report, CG report, sleep 
in chair due to SOB or not 
Some patients are not excellent 
historians or reporters of dyspnea; 
dementia 
Many patients' dementia prevents 
accurate understanding and 
documentation 
Giving objective findings ok, but 
giving & reporting subjective findings 
is difficult. 
Increased respirations, labored 
breathing, chest retractions, 
exhaustion 
Time during visit. Treatment 
management 
Documentation sometimes doesn't 
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Appendix J - Post-Test Qualitative Data 
 
QUALITATIVE 







Use in the future? Why or 
why not? 
What changes have 
you made in 
assessing dyspnea 
after using the 
template 
Comments or 





assessment of a 
symptom like 
dyspnea 
#2 is helpful #1 is least helpful 
I think I can assess the patient 
for dyspnea w/o the template. 
It's too detailed and the 
patient I assessed didn't want 
to answer with a number, 





specifics about total 
scores and interventions 




(I only had an 
opportunity for ONE 
patient.) 
Easy, quick 





No-difficult for patient to 
answer w/o stories or 
qualifications of answers 
Better idea of 
what/how to ask 
dyspnea questions 
Patients had difficulty 
rating 0-3. Always 
wanted to qualify 
answers, i.e. with or w/o 




with patient that 
may not have 
happened before. 




Yes, but would modify and 
make a few changes. 
I address dyspnea 
more openly and ask 
for further 
clarification. 
Overall, I thought it was 
helpful, and hopefully 
identified patients who 
have been saying "no" to 
SOB in the past. 
Important for nurses to 
ask the patient more 
questions than just 
"Are you SOB-yes or 
no." Emphasized the 
importance of sleeping 
in bed, pillows, and 
effect on overall 
breathing. Therefore, 
important questions 
for nurses to ask. 
The questions 
about why they 
sleep elevated or 
not 
The grading of the 
answers 
No, I did not learn anything 
new that I didn't already know 
about my patients. 
If they sleep in a 
regular bed and 
elevated whether it 
is for breathing or 
just for comfort -
muscle vs. GERD 
I disliked the none-mild-
moderate-severe. Felt it 
should have been 
worded never-rarely-
sometimes-frequently 
See # 17. 







The statement "these 
days" does this mean 
in the last 2-3 days? 
Last week? Last 
month? Since I 
assessed you last? It 
wasn't clear to me if 
the statements 
pertained to the 
veteran "at rest" vs. 
"w/activity". 
Portions - Like statement #2, 




"Tell the patient we are 
testing a new way of 
asking "our veterans" 
about their breathing. I'm 
going to read a statement 
and ask you to respond if 
that is true for you - if it 
is true - then is it mildly, 
moderately, or 
completely/severely true. 
Have 2 columns to 
score--one for at rest, 
one for w/exertion. 
The vets with 
respiratory difficulties 
seem to appreciate the 
concern shown w/a 
questionnaire such as 
this. The vets (some) 





Very easy to use Nothing 
Yes: I learned more about 
dyspnea in my patients. I 
didn't know how short of 
breath some of them really 
are. 
Check more 




changed from bed to 
recliner or increased 
HOB and I was not 
aware.  
Easy to use. Maybe 
make it clearer for the 
patients. 
It was interesting and 
helpful. 
The first few 
questions 
Too confusing 
questions for patients 
Yes, but only with patients 
who actually have dyspnea. 
Able to get more 
detail. No response No response 
Full assessment 
on pulmonary Nothing Yes 
Ask same questions 
but in an easier way 
to start. I always 
struggled with the 
starting part because 
it felt backward. 
No response No response 
The template No response Yes: helpful pulling answers from the vets 
Any increase in 
dyspnea No response No response 
It is helpful with 
a patient you are 
not familiar with 







descriptors. They felt 
like they were asking 
the same thing. 
Yes, I think it is helpful for 
the initial assessment and in 
recognizing a change in 
dyspnea. 




identify with better 
in terms of their 
dyspnea.  
No response No response 
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limitation, damages for loss of profits, information or interruption) arising out of the use or inability to use the Licensed Material or the inability to obtain additional rights to use the 
Licensed Material.  To the fullest extent permitted by law, the maximum aggregate liability of the BMJ Group for any claims, costs, proceedings and demands for direct losses caused by 
BMJ Group's breaches of its obligations herein shall be limited to twice the amount paid by you to CCC for the licence granted herein. 
10. Indemnity: You hereby indemnify and hold harmless the BMJ Group and their respective officers, directors, employees and agents, from and against any and all claims, costs, 
proceeding or demands arising out of your unauthorised use of the Licensed Material.  
  
11. No Transfer of License: This licence is personal to you, and may not be assigned or transferred by you without prior written consent from the BMJ Group or its authorised agent(s). 
BMJ Group may assign or transfer any of its rights and obligations under this Agreement, upon written notice to you.  
12. No Amendment Except in Writing: This licence may not be amended except in a writing signed by both parties (or, in the case of BMJ Group, by CCC on the BMJ Group's 
behalf). 
13. Objection to Contrary terms:  BMJ Group hereby objects to any terms contained in any purchase order, acknowledgment, check endorsement or other writing prepared by you, 
which terms are inconsistent with these terms and conditions or CCC's Billing and Payment Terms and Conditions.  These terms and conditions, together with CCC's Billing and 
Payment Terms and Conditions (which to the extent they are consistent are incorporated herein), comprise the entire agreement between you and BMJ Group (and CCC) and the 
Licensee concerning this licensing transaction. In the event of any conflict between your obligations established by these terms and conditions and those established by CCC's Billing and 
Payment Terms and Conditions, these terms and conditions shall control. 
14. Revocation: BMJGroup or CCC may, within 30 days of issuance of this licence, deny the permissions described in this licence at their sole discretion, for any reason or no reason, 
with a full refund payable to you should you have not been able to exercise your rights in full.  Notice of such denial will be made using the contact information provided by you.  Failure 
to receive such notice from BMJGroup or CCC will not, to the fullest extent permitted by law alter or invalidate the denial. For the fullest extent permitted by law in no event will BMJ 
Group or CCC be responsible or liable for any costs, expenses or damage incurred by you as a result of a denial of your permission request, other than a refund of the amount(s) paid by 
you to BMJ Group and/or CCC for denied permissions. 
15. Restrictions to the license: 
15.1 Promotion: BMJ Group will not give permission to reproduce in full or in part any Licensed Material for use in the promotion of the following: 
a) Non-medical products that are harmful or potentially harmful to health: alcohol, baby milks and/or, sunbeds 
b) Medical products that donor have a product license granted by the Medicines and Healthcare products Regulatory Agency (MHRA) or its international equivalents.  Marketing of the 
product may start only after data sheets have been released to members of the medical profession and must conform to the marketing authorization contained in the product license. 
16.       Translation: This permission is granted for non-exclusive world English language rights only unless explicitly stated in your licence. If translation rights are granted, a 
professional translator should be employed and the content should be reproduced word for word preserving the integrity of the content. 
17.        General: Neither party shall be liable for failure, default or delay in performing its obligations under this Licence, caused by a Force Majeure event which shall include any act 
of God, war, or threatened war, act or threatened act of terrorism, riot, strike, lockout, individual action, fire, flood, drought, tempest or other event beyond the reasonable control of 
either party.  
 17.1      In the event that any provision of this Agreement is held to be invalid, the remainder of the provisions shall continue in full force and effect.  
 17.2      There shall be no right whatsoever for any third party to enforce the terms and conditions of this Agreement. The Parties hereby expressly wish to exclude the operation of the 
Contracts (Rights of Third Parties) Act 1999 and any other legislation, which has this effect and is binding on this agreement.  
 17.3      To the fullest extent permitted by law, this Licence will be governed by the laws of England and shall be governed and construed in accordance with the laws of England. Any 
action arising out of or relating to this agreement shall be brought in courts situated in England save where it is necessary for BMJ Group for enforcement to bring proceedings to bring 
an action in an alternative jurisdiction.  
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or +1-978-646-2777. 
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable license for your reference. No payment is required. 
 
 
 
 
